Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingxin Liu

Showing results (151-160 of 157) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 157 results.
International Journal of Cardiology|February 15, 2014
HTUPA as a new thrombolytic agent for acute myocardial infarction: a multicenter, randomized studyYingxian Sun, Xingli Liu, Liang Guo, et al.
Science Advances|June 5, 2024
HMMR triggers immune evasion of hepatocellular carcinoma by inactivation of phagocyte killingHong Wu, Yiqiang Liu, Qianshi Liu, et al.
The Lancet Regional Health. Western Pacific|October 13, 2025
Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trialJinqi Xue, Huilian Shan, Fang Qiu, et al.
Journal of Advanced Research|April 8, 2026
Landscape of volatile organic compounds for differential diagnosis, pathological typing, and severity prediction in lung cancer: a large population-based prospective studyRun Xiang, Peihong Hu, Mingxin Liu, et al.
Nature Communications|July 2, 2025
Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trialNan Niu, Jinqi Xue, Guanglei Chen, et al.
Cancer Research|July 11, 2023
Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell CarcinomaHong Wu, Xuefeng Leng, Qianshi Liu, et al.
Mechanisms of Ageing and Development|July 22, 2020
Lack of consensus on an aging biology paradigm? A global survey reveals an agreement to disagree, and the need for an interdisciplinary frameworkAlan A Cohen, Brian K Kennedy, Ulrich Anglas, et al.
Pageof 16

Showing results (151-160 of 157) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
International Journal of Cardiology|February 15, 2014
HTUPA as a new thrombolytic agent for acute myocardial infarction: a multicenter, randomized studyYingxian Sun, Xingli Liu, Liang Guo, et al.
Science Advances|June 5, 2024
HMMR triggers immune evasion of hepatocellular carcinoma by inactivation of phagocyte killingHong Wu, Yiqiang Liu, Qianshi Liu, et al.
The Lancet Regional Health. Western Pacific|October 13, 2025
Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trialJinqi Xue, Huilian Shan, Fang Qiu, et al.
Journal of Advanced Research|April 8, 2026
Landscape of volatile organic compounds for differential diagnosis, pathological typing, and severity prediction in lung cancer: a large population-based prospective studyRun Xiang, Peihong Hu, Mingxin Liu, et al.
Nature Communications|July 2, 2025
Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trialNan Niu, Jinqi Xue, Guanglei Chen, et al.
Cancer Research|July 11, 2023
Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell CarcinomaHong Wu, Xuefeng Leng, Qianshi Liu, et al.
Mechanisms of Ageing and Development|July 22, 2020
Lack of consensus on an aging biology paradigm? A global survey reveals an agreement to disagree, and the need for an interdisciplinary frameworkAlan A Cohen, Brian K Kennedy, Ulrich Anglas, et al.
Pageof 16